Midtown Pfizer tower to undergo independent review after structural failure prompts code rethink

New York City's Department of Buildings has ordered a third‑party independent review of the Pfizer building's conversion in Midtown after a structural failure prompted a mass evacuation. The project added 14 floors to a 33‑story, about 667,000‑square‑foot tower, and did not require outside peer review under current thresholds, prompting calls from engineers to lower those thresholds, especially for older buildings. City officials say policy changes could be considered as the investigation continues to determine the cause, which could involve reinforcement issues, contractor error, or inspection gaps; the cost of a peer review is typically modest, around $100,000–$200,000.
- Buckled Midtown tower's plans weren't peer reviewed. Some engineers say they should've been. Gothamist
- New York City Officials Inspecting Other Buildings After Midtown High Rise Buckled WSJ
- New York’s Department of Investigation launches inquiry into buckling Manhattan high-rise CNN
- Union Leaders Cite Inspection Process in Pfizer Conversion’s Near-Collapse Commercial Observer
- MetroLoft Buys Next Office Conversion Target: The N.Y. Deal Sheet (July 14, 2026) Bisnow
Reading Insights
1
1
6 min
vs 7 min read
92%
1,282 → 97 words
Want the full story? Read the original article
Read on Gothamist